Medication info
Tenegreen Duo Extended-Release Tablet 10/500mg

Tenegreen Duo Extended-Release Tablet 10/500mg

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›13mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Jinyang Pharmaceutical Co., Ltd.
Appearance
Orange, egg-shaped extended-release film-coated tablet
Packaging
30 tablets per bottle
Approval status
Active

MFDS item code 202201440 · Approved 2022.04.04 · Insurance code 650304310

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this drug should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This drug is generally administered once daily with the evening meal, and the dose should be increased gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this drug 20/1000mg extended-release tablets once daily. Patients taking this drug 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this drug should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this drug, treatment may be initiated at the patient's current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored and the dose adjusted appropriately. When coadministered with a sulfonylurea, reducing the dose of the sulfonylurea may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this drug have not been specifically evaluated in patients switched to this drug from another antihyperglycemic agent. Because changes may affect blood glucose control, any changes in the treatment of patients with type 2 diabetes mellitus should be made under careful monitoring. To maintain the extended-release properties, this drug should be swallowed whole and not split, crushed, ground, or chewed.

Ingredients

Manufacturer
Jinyang Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication helps patients with type 2 diabetes achieve better blood glucose control when taken along with diet and exercise. The combination of teneligliptin and metformin works together to stabilize blood sugar levels and assists in overall diabetes management. Consistent use and lifestyle improvements can lead to healthy blood glucose control.

How to take

Adult dose

The dose of this drug should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This drug is generally administered once daily with the evening meal, and the dose should be increased gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this drug 20/1000mg extended-release tablets once daily. Patients taking this drug 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this drug should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this drug, treatment may be initiated at the patient's current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored and the dose adjusted appropriately. When coadministered with a sulfonylurea, reducing the dose of the sulfonylurea may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this drug have not been specifically evaluated in patients switched to this drug from another antihyperglycemic agent. Because changes may affect blood glucose control, any changes in the treatment of patients with type 2 diabetes mellitus should be made under careful monitoring. To maintain the extended-release properties, this drug should be swallowed whole and not split, crushed, ground, or chewed.

Precautions

This medication is used to assist in controlling blood sugar levels for diabetic patients. However, it should not be administered to patients with moderately reduced kidney function or those with severe heart disease or poor liver function. Additionally, patients scheduled for tests using radiocontrast iodine should discontinue this medication 48 hours prior to the test and only resume after confirming normal kidney function post-testing. Women who are pregnant or may become pregnant should avoid taking this medication. Caution should be exercised as taking this medication with other diabetes treatments can result in hypoglycemia, and patients should be well-informed about the symptoms and management of hypoglycemia. Rarely, lactic acidosis may occur during treatment, which can start with symptoms such as muscle pain, weakness, difficulty breathing, and abdominal pain, and can be life-threatening in severe cases, so immediate consultation with healthcare personnel is advised if suspected symptoms arise. Regular monitoring of liver and kidney function is important during treatment, particularly for elderly patients who may have reduced kidney function. Moreover, alcohol consumption can increase the risk of lactic acidosis, hence it is advisable to avoid drinking during treatment. Vitamin B12 levels may decrease during the course of the treatment, thus regular blood tests are recommended. If undergoing surgery or experiencing severe infection, trauma or other conditions affecting overall health, this medication should be temporarily discontinued until recovery. This medication should be stored out of reach of children, and any unusual symptoms or suspected side effects during treatment must be discussed immediately with a physician.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • hypoglycemia
  • constipation
  • intestinal obstruction
  • liver dysfunction
  • interstitial pneumonia
  • pemphigoid
  • acute pancreatitis
  • dizziness
Show 125 more
  • abdominal distension
  • abdominal discomfort
  • nausea
  • abdominal pain
  • bloating
  • stomatitis
  • gastric polyp
  • colonic polyp
  • duodenal ulcer
  • gastroesophageal reflux disease
  • diarrhea
  • decreased appetite
  • elevated amylase
  • elevated lipase
  • elevated AST(GOT)
  • elevated ALT(GPT)
  • elevated GGT
  • elevated ALP
  • proteinuria
  • ketonuria
  • potential hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • elevated CK(CPK)
  • increased serum potassium concentration
  • fatigue
  • allergic rhinitis
  • elevated serum uric acid
  • peripheral edema
  • hypoglycemia
  • tremors
  • headache
  • weakness
  • hunger
  • fatigue
  • facial edema
  • dyspepsia
  • nausea
  • viral upper respiratory infection
  • shingles
  • rhinitis
  • sweating
  • diabetic retinopathy
  • decreased vision
  • cough
  • pulmonary congestion
  • dyspnea
  • drug overdose
  • benign prostatic hyperplasia
  • headache
  • diarrhea
  • epigastric pain
  • gastritis
  • limb pain
  • upper respiratory infection
  • cerebral infarction
  • hyperglycemia
  • liver biopsy
  • decreased neutrophil count
  • blood sugar abnormalities
  • increased blood sugar
  • increased blood pressure
  • hepatic coma
  • lumbar spinal canal stenosis
  • intervertebral disc protrusion
  • intervertebral disc disorder
  • spinal ligament ossification
  • foraminal stenosis
  • rotator cuff syndrome
  • bladder mass
  • ureteral calculi
  • urinary stones
  • coronary artery disease
  • unstable angina
  • gastroesophageal reflux disease
  • gastric polyp
  • gastritis
  • bile duct obstruction
  • chronic cholecystitis
  • soft tissue infection
  • pneumonia
  • cataract
  • depression
  • iliac artery stenosis
  • dizziness
  • benign prostatic hyperplasia
  • knee surgery
  • dizziness
  • diabetic neuropathy
  • sensory disturbances
  • decreased sensation
  • tension-type headache
  • peripheral neuropathy
  • facial paralysis
  • sciatica
  • orthostatic dizziness
  • hearing loss
  • endolymphatic hydrops
  • increased blood creatinine
  • increased blood urea
  • anemia
  • food allergies
  • pressure ulcer
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • hyperparathyroidism
  • angina
  • ear pain
  • iron deficiency anemia
  • benign prostatic hyperplasia
  • ovarian cyst
  • vulvar pruritus
  • menopausal symptoms
  • toxic hepatitis
  • non-alcoholic fatty liver disease
  • alcoholic liver disease
  • eyelid injury
  • ligament sprain
  • lip injury
  • contusion

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect from air, and it is recommended to keep it at room temperature, between 1 to 30 degrees Celsius. Storing it this way helps maintain its effectiveness and safety.

Appearance and packaging

Appearance

Orange, egg-shaped extended-release film-coated tablet

Package unit

30 tablets per bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.